Emergence Therapeutics Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 10

Employees

  • Latest Deal Type
  • M&A

Emergence Therapeutics General Information

Description

Developer of novel immuno-therapeutics designed to treat high-risk cancers. The company's therapeutics use ATAC technology embracing innovative antibody design, linker technology, and the payload amanitin to target Nectin-4 which is an important and validated target for a broad range of cancers, enabling doctors and healthcare organizations to get an effective drug as a therapy tool to treat cancer.

Contact Information

Website
www.emergencetx.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Schifferstrasse 210
  • 47059 Duisburg
  • Germany
Primary Industry
Pharmaceuticals
Acquirer
Lilly USA
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Schifferstrasse 210
  • 47059 Duisburg
  • Germany

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Emergence Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 01-Aug-2023 Completed Generating Revenue
3. Early Stage VC (Series A) 07-Dec-2021 Completed Generating Revenue
2. Seed Round 25-Nov-2020 Completed Generating Revenue
1. Joint Venture 26-Nov-2019 Completed Startup
To view Emergence Therapeutics’s complete valuation and funding history, request access »

Emergence Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of novel immuno-therapeutics designed to treat high-risk cancers. The company's therapeutics use ATAC technolo
Pharmaceuticals
Duisburg, Germany
10 As of 2023

Karachi, Pakistan

Vienna, Austria
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Emergence Therapeutics Competitors (70)

One of Emergence Therapeutics’s 70 competitors is Pfizer Pakistan, a Corporation company based in Karachi, Pakistan.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Pfizer Pakistan Corporation Karachi, Pakistan
Pfizer (Vienna) Corporation Vienna, Austria
Northwest Biotherapeutics Corporation Bethesda, MD
TG Therapeutics Corporation Morrisville, NC
Renova Therapeutics Venture Capital-Backed Carlsbad, CA
You’re viewing 5 of 70 competitors. Get the full list »

Emergence Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Emergence Therapeutics Former Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
Bpifrance Sovereign Wealth Fund Minority
Eurazeo Asset Manager Minority
Gründerfonds Ruhr Venture Capital Minority
Hadean Ventures Venture Capital Minority
Heidelberg Pharma Research GmbH Corporation Minority
You’re viewing 5 of 13 investors. Get the full list »

Ready to get started?

Request a free trial

Emergence Therapeutics FAQs

  • When was Emergence Therapeutics founded?

    Emergence Therapeutics was founded in 2019.

  • Where is Emergence Therapeutics headquartered?

    Emergence Therapeutics is headquartered in Duisburg, Germany.

  • What is the size of Emergence Therapeutics?

    Emergence Therapeutics has 10 total employees.

  • What industry is Emergence Therapeutics in?

    Emergence Therapeutics’s primary industry is Pharmaceuticals.

  • Is Emergence Therapeutics a private or public company?

    Emergence Therapeutics is a Private company.

  • What is Emergence Therapeutics’s current revenue?

    The current revenue for Emergence Therapeutics is .

  • How much funding has Emergence Therapeutics raised over time?

    Emergence Therapeutics has raised $98.8M.

  • Who are Emergence Therapeutics’s investors?

    Bpifrance, Eurazeo, Gründerfonds Ruhr, Hadean Ventures, and Heidelberg Pharma Research GmbH are 5 of 13 investors who have invested in Emergence Therapeutics.

  • Who are Emergence Therapeutics’s competitors?

    Pfizer Pakistan, Pfizer (Vienna), Northwest Biotherapeutics, TG Therapeutics, and Renova Therapeutics are some of the 70 competitors of Emergence Therapeutics.

  • When was Emergence Therapeutics acquired?

    Emergence Therapeutics was acquired on 01-Aug-2023.

  • Who acquired Emergence Therapeutics?

    Emergence Therapeutics was acquired by Lilly USA.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process